Axcelis Technologies ACLS Ion Implantation Systems Services And Royalties — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Axcelis Technologies in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Axcelis Technologies’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axcelis Technologies's ion implantation systems services and royalties — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axcelis Technologies's ion implantation systems services and royalties — revenue?
- Axcelis Technologies (ACLS) reported ion implantation systems services and royalties — revenue of $206.02M in Q4 2025.
- How has Axcelis Technologies's ion implantation systems services and royalties — revenue changed year-over-year?
- Axcelis Technologies's ion implantation systems services and royalties — revenue decreased by 17.7% year-over-year, from $250.26M to $206.02M.
- What is the long-term trend for Axcelis Technologies's ion implantation systems services and royalties — revenue?
- Over 4 years (2021 to 2025), Axcelis Technologies's ion implantation systems services and royalties — revenue has grown at a 6.3% compound annual growth rate (CAGR), from $645.5M to $824.1M.
- What does ion implantation systems services and royalties — revenue mean?
- This metric represents the total revenue generated from the aftermarket lifecycle support of ion implantation equipment, including spare parts, maintenance services, equipment upgrades, and technical training. It reflects the company's ability to monetize its installed base of semiconductor manufacturing tools through recurring service contracts and long-term customer support engagements. This revenue stream is a critical indicator of the company's operational stability and the ongoing utility of its equipment in customer fabrication facilities.